News

USP Prescription Container Labeling Chapter is Now the Official Standard

Topics: Prescription label

The United States Pharmacopeia (USP) General Chapter <17> Prescription Container Labeling, published in the USP 36–NF 31, became an official standard on May 1, 2013.

Read More →

NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health

Topics: Counterfeit drugs and Patient safety

To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program. 

Read More →

US Senate Committee Proposes Legislation to Create Compounding Manufacturer Category to Be Under FDA Regulation

Topics: Compounding

Federal lawmakers have drafted legislation that would create a new category of drug compounders, “compounding manufacturers,” to be regulated by Food and Drug Administration (FDA). 

Read More →

Sixth DEA Take-Back Day Collects Over 740,000 Pounds of Unneeded Medication, Helping to Prevent Diversion and Abuse

Topics: Medication collection program disposal and Dea

The Drug Enforcement Administration's (DEA) sixth National Prescription Drug Take-Back Day on April 27, 2013, collected twice the amount of unneeded and expired medications for safe disposal than the previous DEA take-back event six months ago.

Read More →

New Jersey State Board of Pharmacy and State’s Attorney General Partner to Provide Pharmacies With Security Best Practice Guidelines

Topics: Diversion and Pharmacies

Best practices for pharmacy security guidelines have been developed by the New Jersey State Board of Pharmacy and the state’s Attorney General to assist pharmacies in preventing drug theft and diversion. 

Read More →

NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health

Topics: Counterfeit drugs and Patient safety

To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program. 

Read More →

FPGEC and FPGEE Fees to Increase Starting in July

Topics: Fpgee and Fpgec

Effective July 1, 2013, the application fees for the Foreign Pharmacy Graduate Examination Committee (FPGEC) certification, which includes taking the Foreign Pharmacy Graduate Equivalency Examination (FPGEE), will increase.

Read More →

Teen Prescription Drug Abuse Rates Rising, Attitudes About Stimulant Abuse of Particular Concern

Topics: Prescription drug abuse

Teen abuse of prescription drugs has increased, in part driven by teens' and parents' attitudes toward stimulant abuse, indicates the latest Partnership Attitude Tracking Study.

Read More →

FDA Warns Providers About Fraudulent, Unapproved Versions of Botox Found in the US

Topics: Counterfeit drugs

Fraudulent, unapproved versions of Botox® are being sold by unlicensed suppliers to US medical practices, warns FDA. 

Read More →

Illegal Online Sellers Fuel Global Spread of Fake and Substandard Medications, International Collaboration Key in Response, Reports NABP

Topics: Buying medicine online and Internet pharmacy

The National Association of Boards of Pharmacy® (NABP®) recently issued a report emphasizing that the global distribution of counterfeit and substandard medications, fueled by illegal online sellers, demands an international response.

Read More →

Two Compounding Pharmacies Recall Sterile Products Over Sterility Assurance Concerns

Topics: Compounding

Two pharmacies have voluntarily recalled their sterile compounded products because of concerns associated with quality control processes and a lack of sterility assurance. 

Read More →